Skip to main content

MoneyWorks4Me

Cipla reports Profit after tax of Rs 3554.90 Mln, in the March 2023 quarter

26 Jul 2023 Evaluate
With no major difference for the quarter endedMarch 2023 , the total revenue stood at Rs. 38937.40  millions.The Company to register a -44.39%  fall in the net profit for the quarter ended March 2023.The company reported a degrowth in operating Profit to 9194.90 millions from 9415.70 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 38937.40 37345.90 4.26 157906.00 153808.20 2.66 157906.00 153808.20 2.66
Other Income 1197.10 3163.10 -62.15 4567.90 6667.00 -31.48 4567.90 6667.00 -31.48
PBIDT 9194.90 9415.70 -2.35 42493.70 43779.30 -2.94 42493.70 43779.30 -2.94
Interest 104.60 57.80 80.97 270.20 269.30 0.33 270.20 269.30 0.33
PBDT 7231.30 9357.90 -22.73 40364.50 43510.00 -7.23 40364.50 43510.00 -7.23
Depreciation 1615.80 1367.20 18.18 5959.10 5466.20 9.02 5959.10 5466.20 9.02
PBT 5615.50 7990.70 -29.72 34405.40 38043.80 -9.56 34405.40 38043.80 -9.56
TAX 2060.60 1598.60 28.90 9710.10 9218.00 5.34 9710.10 9218.00 5.34
Deferred Tax -385.80 -0.50 77060.00 -400.90 -276.90 44.78 -400.90 -276.90 44.78
PAT 3554.90 6392.10 -44.39 24695.30 28825.80 -14.33 24695.30 28825.80 -14.33
Equity 1614.30 1613.60 0.04 1614.30 1613.60 0.04 1614.30 1613.60 0.04
PBIDTM(%) 23.61 25.21 -6.34 26.91 28.46 -5.46 26.91 28.46 -5.46
Peers
Company Name CMP
Sun Pharma. Inds. 1906.60
Dr. Reddys Labs. 1373.55
Cipla 1408.85
Lupin 1993.65
Zydus Lifesciences 1201.45
View more..